![Kinneret Livnat Savitsky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kinneret Livnat Savitsky
Director/Miembro de la Junta en Biomica Ltd. .
Cargos activos de Kinneret Livnat Savitsky
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Biomica Ltd.
![]() Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Director/Miembro de la Junta | - | - |
Historial de carrera de Kinneret Livnat Savitsky
Antiguos cargos conocidos de Kinneret Livnat Savitsky.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MabTrix Ltd.
![]() MabTrix Ltd. Pharmaceuticals: MajorHealth Technology MabTrix Ltd. develops biopharmaceutical products. It develops innovative function-blocking therapeutic monoclonal antibody for inflammatory bowel disease. The company was founded in December 2015 and is headquartered in Ness Ziona, Israel. | Director/Miembro de la Junta | 10/05/2018 | - |
Estadísticas
Internacional
Israel | 3 |
Operativa
Director/Board Member | 2 |
Sectorial
Commercial Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Biomica Ltd.
![]() Biomica Ltd. Miscellaneous Commercial ServicesCommercial Services Biomica Ltd. engages in the provision of biopharmaceutical services. Its technology focuses on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. The company was founded by Yehuda Ringel in 2017 and is headquartered in Rehovot, Israel. | Commercial Services |
MabTrix Ltd.
![]() MabTrix Ltd. Pharmaceuticals: MajorHealth Technology MabTrix Ltd. develops biopharmaceutical products. It develops innovative function-blocking therapeutic monoclonal antibody for inflammatory bowel disease. The company was founded in December 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |